Summary
The majority of all acute upper respiratory tract infections (URTIs) are viral in aetiology. Bacterial infection, either as a prime cause or secondary to the initial viral infection, can be effectively eradicated with appropriate drug therapy. A course of penicillin is usually effective in cases of acute tonsillitis, pharyngitis, otitis media and sinusitis. Macrolide antibiotics may be prescribed as an alternative, especially if β-lactamase-producing strains are present. Roxithromycin achieves high tissue concentrations, and cure rates between 85 and 100% have been reported in various URTIs.
Article PDF
Similar content being viewed by others
References
Bluestone CD. Otitis media and sinusitus in children. Role of Branhamella catarrhalis. Drugs 31(Suppl. 3): 132–141, 1986
Brook I, Yocum P. Friedman EM. Aerobic and anaerobic bacteria in tonsils of children with recurrent tonsillitis. Annals of Otology, Rhinology and Laryngology 90: 261, 1981
D’Enfert J, Fiessinger S. Rulid: un nouveau macrolide efficace en pathologie O.R.L. Les Cahiers d’O.R.L. 23: 141–143, 1988
Grassi C, Bartucci F, Sassella D. Efficacy and safety of rox-ithromycin in respiratory tract infections. British Journal of Clinical Practice 42(Suppl. 55): 104–105, 1988
Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. New England Journal of Medicine 308: 1443, 1983
Herron JM. Roxithromycin in the therapy of Streptoccocus pyogenes throat infection. Journal of Antimicrobial Chemotherapy 20(Suppl. B): 139–144, 1987
Jackson RT, Todd WW, Turner Jr JS. Ear, nose and throat diseases in Speight TM (Ed.) Avery’s drug treatment. Principles and practice of clinical pharmacology and therapeutics, 3rd ed., pp. 360–386, Adis Press Ltd, Auckland, 1987
Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis: placebo-controlled double-blind evaluation of clinical response to penicillin therapy. Journal of the American Medical Association 253: 1271, 1985
Matsumoto F, Hara K. Multicentre clinical studies of roxithromycin in respiratory, otorhinolaryngological, skin and dental infections, and chlamydial sexually transmitted diseases. 15th International Congress of Chemotherapy, Istanbul, July 19–24, 1987
Melcher GP. Comparative efficacy and toxicity of roxithromycin and erythromycin ethylsuccinate in the treatment of Streptococcal pharyngitis in adults. Journal of Antimicrobial Chemotherapy 22: 549–556, 1988
Soyka LF, Robinson DS, Lachant N, Monaco J. The misuse of antibiotics for treatment of upper respiratory tract infections in children. Pediatrics 55: 552, 1975
Taylor B, Abbott GD, Kerr MMcK, Fergusson DM. Amoxycillin and co-trimoxazole in presumed viral respiratory infections of childhood: placebo-controlled trial. British Medical Journal 2: 552, 1977
Young RA, Gonzalez JP, Sorkin EM. Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37: 8–41, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gómez-Barreto, D. The Place of Macrolides in the Treatment of Upper Respiratory Tract Infections. Drug Invest 3 (Suppl 3), 17–20 (1991). https://doi.org/10.1007/BF03258330
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03258330